Carrier-mediated transport in the hepatic distribution and elimination of drugs, with special reference to the category of organic cations.
about
Role of the plasma membrane transporter of organic cations OCT1 and its genetic variants in modern liver pharmacologyMolecular and cellular physiology of renal organic cation and anion transport.Organotypic liver culture models: meeting current challenges in toxicity testing.Twelve transmembrane helices form the functional core of mammalian MATE1 (multidrug and toxin extruder 1) proteinMATE1 has an external COOH terminus, consistent with a 13-helix topology.Substrate-dependent inhibition of human MATE1 by cationic ionic liquids.Renal transport of organic anions and cations.Polyspecific organic cation transporters and their impact on drug intracellular levels and pharmacodynamics.An introduction to drug disposition: the basic principles of absorption, distribution, metabolism, and excretion.The disposition of morphine and its 3- and 6-glucuronide metabolites in humans and animals, and the importance of the metabolites to the pharmacological effects of morphine.Membrane transport as a determinant of the hepatic elimination of drugs and metabolites.Inward transport of [3H]-1-methyl-4-phenylpyridinium in rat isolated hepatocytes: putative involvement of a P-glycoprotein transporterFunctional map of TEA transport activity in isolated rabbit renal proximal tubules.Effects of non-steroidal anti-inflammatory drugs on the pharmacokinetics and elimination of aciclovir in rats.Characterization of tetraethylammonium uptake across the basolateral membrane of the Drosophila Malpighian (renal) tubule.Contribution of the murine mdr1a P-glycoprotein to hepatobiliary and intestinal elimination of cationic drugs as measured in mice with an mdr1a gene disruption.
P2860
Q27026858-2EF379DA-9776-486D-8DB6-9F4357194F81Q35842999-207E6D4A-BB1A-46DE-BBEC-76A6419CE294Q36178225-819E29C2-C9D1-4D33-8F9D-B496C90C59C6Q36201747-18C198FF-5E2E-4FE0-B9BB-D0DA26660AE4Q37298471-A1CD6FE8-ACE3-4E95-862B-C9E359C86BC6Q37422651-E7A3E335-7529-4F89-B1FB-9B180B2EBD08Q38111725-65738EA6-3E41-4C20-AD0C-36FF36B74691Q38851414-61B34B0B-42D7-4282-B5DD-55F9F5D6430EQ40418686-FAAF380C-603B-4535-887C-4315E1FDF3D6Q41170052-5F3A6D77-CC85-4989-A978-BECC2CD94B0DQ41205210-0ED31EFF-A9B6-47B4-8E9C-6D6D810DCAEBQ42581775-D9D827F9-9446-4DE8-AA8E-44E467EF292EQ44883038-10FF0332-1A03-4265-B344-1A12D4D0829BQ46419815-DB7E2CB7-8865-4E9E-BAEE-C3BC9AC77448Q46463064-38E53C98-6BEC-49F7-9A69-10E68C6EB7ADQ52530011-39A17596-0C90-4E94-A55E-68967AAEAB84
P2860
Carrier-mediated transport in the hepatic distribution and elimination of drugs, with special reference to the category of organic cations.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Carrier-mediated transport in ...... e category of organic cations.
@en
Carrier-mediated transport in ...... e category of organic cations.
@nl
type
label
Carrier-mediated transport in ...... e category of organic cations.
@en
Carrier-mediated transport in ...... e category of organic cations.
@nl
prefLabel
Carrier-mediated transport in ...... e category of organic cations.
@en
Carrier-mediated transport in ...... e category of organic cations.
@nl
P2093
P2860
P356
P1476
Carrier-mediated transport in ...... e category of organic cations.
@en
P2093
P2860
P2888
P356
10.1007/BF01063621
P577
1990-02-01T00:00:00Z